Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells.
Autor: | Chin YT; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Wei PL; Division of Colorectal Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.; Cancer Research Center and Translational Laboratory, Department of Medical Research, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.; Department of Surgery, College of Medicine; Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan., Ho Y; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan., Nana AW; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei, Taiwan., Changou CA; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; Core Facility, Taipei Medical University, Taipei, Taiwan.; Integrated Laboratory, Center of Translational Medicine, Taipei Medical University, Taipei, Taiwan., Chen YR; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Yang YS; Joint Biobank, Office of Human Research, Taipei Medical University, Taipei, Taiwan., Hsieh MT; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Hercbergs A; Department of Radiation Oncology, The Cleveland Clinic, Cleveland, Ohio, USA., Davis PJ; Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Albany, New York, USA.; Department of Medicine, Albany Medical College, Albany, New York, USA., Shih YJ; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Lin HY; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; Traditional Herbal Medicine Research Center of Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan. |
---|---|
Jazyk: | angličtina |
Zdroj: | Endocrine-related cancer [Endocr Relat Cancer] 2018 May; Vol. 25 (5), pp. 533-545. Date of Electronic Publication: 2018 Mar 19. |
DOI: | 10.1530/ERC-17-0376 |
Abstrakt: | Thyroid hormone, l-thyroxine (T (© 2018 Society for Endocrinology.) |
Databáze: | MEDLINE |
Externí odkaz: |